Publications by authors named "Roberta Poli"

Claim this Profile
E
Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System.
Soraya Puglisi, Alessandro Rossini, Roberta Poli, Francesca Dughera, Anna Pia

Front Endocrinol (Lausanne)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignant struma ovarii: next-generation sequencing of six cases revealed Nras, Braf, and Jak3 mutations.
Roberta Poli, Maria Scatolini, Enrico Grosso, Francesca Maletta, Marco Gallo

Endocrine· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Malignant struma ovarii: next-generation sequencing of six cases revealed Nras, Braf, and Jak3 mutations.
Roberta Poli, Maria Scatolini, Enrico Grosso, Francesca Maletta, Marco Gallo

Endocrine· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone deacetylase inhibition modulates E-cadherin expression and suppresses migration and invasion of anaplastic thyroid cancer cells.
Maria Graziella Catalano, Nicoletta Fortunati, Mariateresa Pugliese, Francesca Marano, Loredana Ortoleva, Roberta Poli

J Clin Endocrinol Metab· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo.
Maria Graziella Catalano, Mariateresa Pugliese, Eleonora Gargantini, Cristina Grange, Benedetta Bussolati, Roberta Poli

Int J Cancer· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging molecular therapies of advanced thyroid cancer.
Maria Graziella Catalano, Roberta Poli, Mariateresa Pugliese, Nicoletta Fortunati, Giuseppe Boccuzzi

Mol Aspects Med· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the histone deacetylase inhibitor valproic acid on the sensitivity of anaplastic thyroid cancer cell lines to imatinib.
Maria Graziella Catalano, Mariateresa Pugliese, Roberta Poli, Ornella Bosco, Raffaello Bertieri

Oncol Rep· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell lines.
Maria G Catalano, Roberta Poli, Mariateresa Pugliese, Nicoletta Fortunati, Giuseppe Boccuzzi

Endocr Relat Cancer· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells.
Maria G Catalano, Nicoletta Fortunati, Mariateresa Pugliese, Roberta Poli, Ornella Bosco

J Endocrinol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells.
Maria G Catalano, Nicoletta Fortunati, Mariateresa Pugliese, Lucia Costantino, Roberta Poli

J Clin Endocrinol Metab· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis